With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Current ACC/AHA guidelines emphasize the need for aggressive modification of risk factors and treatment with antiplatelet, antihypertensive, and lipid-lowering agents, and evidence suggests that many physicians fail to adhere to these guidelines. This educational initiative will engage physicians in a self-assessment activity developed specifically to address knowledge and competency in the management of patients with ACS.
Join Drs. Zipes and Sweeney for a discussion on the differences in effects of electrical therapy type for ventricular arrhythmias on mortality in ICD patients.
Dr. Hugh Calkins leads a panel of experts, Drs. Berger, Hocini, and Jalife, as they review the impact of AF and discuss the management strategies to avoid the consequences of AF or to restore normal function.
Drs. Storey, Kereiakes, and Montalescot discuss the use of point-of-care testing to assess antiplatelet responsiveness, including strategies for treating poor responders.
Read Dr. Kaszala's clinical update, "How Evolving Sensor Technology and Rate-Responsive Pacing Can Improve Clinical Outcomes in CI." Then join him and Dr. Ellenbogen as they present 3 case studies and further discuss this important topic.
Join Drs. Hacke and Diener as they give a neurologist's perspective on the potential impact of novel anticoagulants on the risk for stroke in patients with AF.
It is becoming clear that dual antiplatelet therapy may need frequent reevaluation and monitoring in patients following an acute coronary syndrome (ACS). Join Drs. Peter P. Toth and Christopher P. Cannon who will address a number of challenging decision points that can occur in the long-term management of these patients.
Data on almost 3000 TAVI patients were presented at EuroPCR 2010. Dr. Moat discusses the topline findings with Drs. Eltchaninoff, Petronio, and Thomas. Then Dr. Manoharan gives the proctor's perspective.
Drs. Weber, Whelton, and Raij review the risks and benefits of current therapies for addressing arthritis pain and assess the potential utility of an emerging class of drug to address pain and maintain target blood pressure.
Drs. Kowey, Camm, Curtis, Mitchell, and Reiffel use an interactive, case-based program to explore more than a dozen topics related to atrial fibrillation, including novel and emerging antiarrhythmic therapies.
Dr. Dorian reviews 2 cases: A 65-year-old with a sudden onset of irregular palpitations and a 84-year-old woman with frequent episodes of palpitations.
This webcast will feature a case-based approach to discuss individualized antiplatelet therapy in a high-risk patient with ST-segment-elevation myocardial infarction.
What dictates choice of antiplatelet therapy? What are the predictors of cardiac events in medically managed patients with ACS? Drs. Ohman, Cohen, and Mehran discuss these important questions based on recent data in the "Late Night Report."
A case-based approach will be used to highlight the latest developments in the individualized initial and long-term management of patients with acute coronary syndrome (ACS) to optimize patient outcomes in the cardiology setting.
Join Dr. Berthrone L. Mock-Muhammad for a case-based lecture on the use of pharmacologic and device therapies for the prevention of sudden cardiac death in heart failure.
The Association of Black Cardiologists continues its commitment to closing the gap in cardiovascular health disparities using multiple, solution-based strategies.